1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Sri Lanka Pharmaceuticals and Healthcare Report Q3 2016

Sri Lanka Pharmaceuticals and Healthcare Report Q3 2016

  • June 2016
  • -
  • Business Monitor International
  • -
  • 68 pages

Includes 3 FREE quarterly updates

BMI View: Despite Sri Lanka's short-term fiscal challenges, the country's pharmaceutical and healthcaremarkets will continue to expand over the forecast period. In fact, under the FY2016 budget, the governmentoutlined the construction and upgrade of several healthcare facilities, which will broaden access to healthservices in the country while strengthening the health system ability to cope with latent and growingdemand for the treatment of chronic diseases. However, public spending figures will observe partial cuts oradjustments as part of the country's recent agreement to secure an international bailout loan, while weexpect pro-generic medicines policies and low per-capita drug spending to limit Sri Lanka's appeal toinnovative pharmaceutical investors.Headline Expenditure Projections

- Pharmaceuticals: LKR82.88bn (USD610mn) in 2015 to LKR90.57bn (USD610mn) in 2016; +9.3 inlocal currency terms and +0.3 in US dollar terms.

Forecast in line with last quarter.

- Healthcare: LKR295.23bn (USD2.17bn) in 2015 to LKR321.31bn (USD2.17bn) in 2016; +8.8 in localcurrency terms and -0.1 in US dollar terms. Forecast revised downwards from last quarter.

Table Of Contents

Sri Lanka Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Sri Lanka 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Sri Lanka 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Sri Lanka 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Sri Lanka 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Sri Lanka 2012-2020) 17
Prescription Drug Market Forecast 18
Pharmaceutical Trade Forecast 20
Table: Pharmaceutical Trade Data And Forecasts (Sri Lanka 2014-2020) 22
Table: Pharmaceutical Trade Data And Forecasts local currency (Sri Lanka 2014-2020) 22
Industry Risk Reward Indices 23
Asia Pacific Risk/Reward Index - Q3 2016 23
Sri Lanka - Risk/Reward Index 29
Rewards 29
Risks 29
Regulatory Review 30
Intellectual Property Issues 33
Pricing And Reimbursement Regimes 34
Market Overview 35
Healthcare Sector 36
Clinical Trials 39
Epidemiology 40
Competitive Landscape 44
Research-Based Industry 44
Table: Multinational Market Activity 45
Pharmaceutical Distribution 46
Pharmaceutical Retail Sector 47
Company Profile 48
GlaxoSmithKline 48
Hemas Holdings 51
State Pharmaceuticals Corporation (SPC) 54
Demographic Forecast 57
Demographic Outlook 57
Table: Population Headline Indicators (Sri Lanka 1990-2025) 58
Table: Key Population Ratios (Sri Lanka 1990-2025) 58
Table: Urban/Rural Population and Life Expectancy (Sri Lanka 1990-2025) 59
Table: Population By Age Group (Sri Lanka 1990-2025) 59
Table: Population By Age Group % (Sri Lanka 1990-2025) 60
Glossary 62
Methodology 64
Pharmaceutical Expenditure Forecast Model 64
Healthcare Expenditure Forecast Model 64
Notes On Methodology 65
Risk/Reward Index Methodology 66
Index Overview 67
Table: Pharmaceutical Risk/Reward Index Indicators 67
Indicator Weightings 68

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.